10.21147/j.issn.1000-9604.2022.06.12
Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)
Melanoma remains a rare malignant tumor with high mortality and increasing incidence in China. Due to ethnic characteristics, acral and mucosal melanomas are the predominant subtypes in Asia, many research advances have been made in melanoma these years, especially for these two subtypes. In keeping with the development of key research on melanoma, the National Health Commission of the People's Republic of China organized experts to revise the Chinese guidelines for diagnosis and treatment of melanoma in 2021, and the National guidelines for diagnosis and treatment of melanoma 2022 in China (English version) was also updated (1).
national、english、china、comments、diagnosis、guidelines、melanoma、treatment、version
34
S;H313;F752.7
2023-04-21(万方平台首次上网日期,不代表论文的发表时间)
共2页
635-636